Seleccione otro país
Bienvenido a Lyxor EspañaWelcome
Por favor, lea la información importante aquí incluida antes de continuar a nuestra página web

Información relevante 

Los Lyxor ETFs presentados en la página web de, pueden ser objeto de restricciones en lo que respecta a la inversión por determinadas personas o en determinados países, en virtud de las distintas regulaciones nacionales aplicables a dichas personas o en dichos países. Cualquier persona que acceda a esta página web desde una jurisdicción en la cual se aplican dichas restricciones tiene que informarse al respecto y observar dichas restricciones. Por consiguiente, le corresponde a usted asegurarse de que, efectivamente está autorizado a invertir en los Lyxor ETFs presentados en esta página web. Invirtiendo en estos productos, usted garantiza a Société Générale que está efectivamente autorizado a invertir. Inversores españoles se deben dirigir a

La información contenida en esta página web no constituye una oferta o invitación para adquirir o vender los productos aquí descritos a personas sometidas a  jurisdicciones donde:

(a) dicha oferta o invitación no esté autorizada;
(b) Lyxor Asset Management no esté cualificada para hacer dicha oferta o invitación;
(c)  sea ilícito hacer dicha oferta o invitación.

Los ETFs referidos en esta página web no han estado y no estarán registrados conforme al U.S Securities Act de1933, por lo tanto, no pueden ser ofertados ni vendidos en los EE.UU sin registro previo o solo en caso de excepción de registro conforme al  al Securities Act. Por consiguiente, los ETFs listados en esta página web no pueden ser vendidos a “U.S persons”, ni transferidos a los Estados Unidos a menos que dicha transacción esté sujeta a los requisitos de registro conforme a la ley Americana.

Esta página web es de carácter comercial y no de carácter legal. No se garantiza la exactitud, exhaustividad o pertinencia de la información aunque ha sido establecida a partir de fuentes consideradas como fiables.
La información presentada en esta página web se basa en información de mercado constada en un momento dado que puede variar con posterioridad a su publicación. El valor de reembolso de los Lyxor ETFs puede ser inferior al montante de la inversión inicial. En el peor de los casos, los inversores podrían perder hasta la totalidad de su inversión, por lo que se recomienda a los inversores consultar la sección« factores de riesgo » del folleto del producto. El precio de algunos Lyxor ETFs puede ser sensible a riesgos de tipo de cambio entre la cotización del ETF y/o la divisa del índice y/o la divisa del componente del índice.

Todos los LyxorETFs presentados en esta página web han sido aprobados por la “Autorité des Marchés Financiers (AMF)” y son objeto de un folleto aprobado por la AMF y pasaporteado en la CNMV conforme a la Directiva 2003/71/CE. Dichos folletos están disponibles en esta página Web.

La documentación relativa a los Lyxor ETFs preverá métodos de ajuste y de sustitución para tener en cuenta que consecuencias tendría cualquier suceso extraordinario que afecte a uno o varios de los subyacentes de estos productos.

Antes de invertir en un Lyxor ETF, usted debe hacer su propia valoración del riesgo desde un punto de vista legal, fiscal y  contable, sin depender exclusivamente de la información que le proporcionamos y consultando, si lo estima necesario, sus propios asesores en la materia o cualquier otro asesor independiente.

El inversor de ETFs estará expuesto a los siguientes factores de riesgo: Riesgo de pérdida del capital invertido, al no existir ninguna garantía, como consecuencia de un movimiento desfavorable del Índice de Referencia, Riesgo de que el objetivo de gestión solo se cumpla parcialmente, Riesgo de contrapartida como resultado de la utilización de los instrumentos financieros (OTC) formalizados con un establecimiento de crédito. Se recomienda a los inversores que consulten la sección del folleto antes de invertir.

En la medida en que cumpla con la legislación aplicable, ninguna entidad del Grupo Société Générale acepta responsabilidad alguna por las consecuencias financieras o de cualquier otra naturaleza que resulten de la inversión en este producto.

24 may 2019

SG Quality Income: an attractive yield that stands the test of time

The stock markets rose strongly over the first few months of the year, but they’ve been struggling in recent weeks due to a resurgence of the trade war between the US and China. Meanwhile, bond yields are still painfully low. One option for investors to navigate this tricky environment could be to allocate to a quality income equity strategy. 

Difficult conditions for investors seeking income

Global economic conditions have been slowly improving since the start of the year and bond yields have sunk even further, with those of European sovereigns now at rock-bottom levels.  How might multi-asset investors react in these circumstances? They have the choice to switch out of bonds into suitable equities or sit tight. Investors believe that economic conditions aren’t going to improve, and that central banks will make ever-more desperate attempts to drive yields lower, they may decide to carry on holding bonds.

We’re in an environment of low interest rates and low corporate bond yields, and that means there are few safe havens for income seekers. One idea for investors wary of making seismic changes to their asset allocation could be to switch from low-quality bonds into high-quality equities – a change that puts balance sheet strength ahead of anything else.

Why might this be an attractive choice? Taken at face value, the potential income available from high yield bonds looks like it should exceed dividends. But high yield bond indices are made up of the lowest-quality companies in the market, and there’s no guarantee they’ll be able to meet their obligations. These bonds therefore have the potential for a lot more risk with little upside.

 SG Quality Income index: providing an attractive yield that stands the test of time

One option for investors looking to allocate to high-income equities could be the SG Quality Income index. It’s an equity index that seeks to provide a dependable, high-quality dividend stream.  Unlike the MSCI World High Dividend index, which tends to outperform the broad global markets on a total return basis but struggles in return-only terms, the SG Quality Income index focuses on corporates that can pay and grow their dividend and aims to maintain its dividend payments regardless of the market backdrop.

By sticking to the same careful, repeatable process, the SG Quality Income index has been able to avoid more than 80% of the major dividend cuts that have taken place since the global financial crisis in 2007. 

Comparison of realised yields for high- and low-quality companies since 1989


Source: SG Cross Asset Research/Equity Quant, FTSE, Factset. Data as at 30/04/2019. Past performance is not a reliable indicator of future performance. 

In constructing the index, we assess each stock based on three criteria:

  • the quality of its business
  • the strength of its balance sheet
  • the level and sustainability of its dividend yield.

See our handy guide for more information

Chart 2

*Yield thresholds may be relaxed to ensure the index contains a minimum number of stocks. Detailed index methodology available on request.

Some important benefits

The high-quality companies that the SG Quality Income index invests in represent an opportunity to access a less volatile area of the equity market. The nature of these businesses is such that their earnings are predictable rather than cyclical, and this means many investors view them as unfashionable. This can result in these kinds of stocks often becoming undervalued.  An extra benefit is that they represent a useful hedge against rising inflation. That’s because the dividends they pay tend to rise in line with prices, unlike fixed-rate securities.

Making money by not losing money

The main reason for the SG Quality Income index’s outperformance of the broad markets over the long term is the protection from drawdowns it offers in falling markets. For example, during the market stress in Q4 2018 the index outperformed the MSCI World by more than 6 percentage points. Its volatility (10.6%) was also significantly lower than that of the MSCI World (16.6%) over the last quarter of last year. As we can see in the following table, high-quality stocks have historically been much less volatile and experienced much lower drawdowns than low-quality stocks. 

Buying better quality companies provide your risk control

(performance by Merton quintiles)

              chart 3

Data based on FTSE World Developed stocks, covers the period from 01/01/1990 to 31/12/2018. Past performance is not a reliable indicator of future performance. Source: SG Cross Asset Research/Equity Quant, FTSE, Factset. 

An attractive option for any kind of investor

If an absolute return investor or multi-asset investor is looking for yield, equity income stocks could look a lot more enticing than sovereign or corporate bonds, which are currently providing historically low yields and offer no protection against inflation.

It’s true that equity income strategies tend to underperform the broad markets when they’re experiencing the kind of irrational exuberance that’s driven them so much higher in recent years. But quality income strategies that value balance sheet strength above all else might be a better option should the markets take another turn for the worse.

And that’s exactly what seems to have been in the minds of European investors this year. European equity income ETFs have received net inflows every month so far in 2019, while broad European equity ETFs have experienced outflows every month.  It seems that now might indeed be a good time to allocate to this kind of strategy.

Net new assets of income generation and broad European equity ETFs in the European ETF market in 2019 (EUR million)

                 Chart 4

Source: Lyxor International Asset Management, Bloomberg, data as at 30 April 2019

 Why choose Lyxor for quality income?

Our quality income indices target only the most robust and stable businesses in the developed world.  We provide indices covering the global stock markets and a strategy specific to Europe. 

   why income

Relevant products

Risk Warning​

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin